Illumina

YTD

ALL

Trade Illumina 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ILMN

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. The company was founded by David R.

CEO

Jacob Thaysen

CEOJacob Thaysen

Employees

8,600

Employees8,600

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

1998

Founded1998

Employees

8,600

Employees8,600

ILMN Key Statistics

Market cap

27.82B

Market cap27.82B

Price-Earnings ratio

31.91

Price-Earnings ratio31.91

Dividend yield

—

Dividend yield—

Average volume

2.17M

Average volume2.17M

High today

$184.90

High today$184.90

Low today

$175.60

Low today$175.60

Open price

$175.83

Open price$175.83

Volume

2.13M

Volume2.13M

52 Week high

$184.90

52 Week high$184.90

52 Week low

$88.00

52 Week low$88.00

Stock Snapshot

Illumina(ILMN) stock is priced at $183.67, giving the company a market capitalization of 27.82B. It carries a P/E multiple of 31.91.

During the trading session on 2026-07-02, Illumina(ILMN) shares reached a daily high of $184.90 and a low of $175.60. At a current price of $183.67, the stock is +4.6% higher than the low and still -0.7% under the high.

Trading activity shows a volume of 2.13M, compared to an average daily volume of 2.17M.

Over the past 52 weeks, Illumina(ILMN) stock has traded between a high of $184.90 and a low of $88.00.

ILMN News

MarketWatch 8h

Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch

...

TipRanks 18h

Illumina price target raised to $200 from $170 at Piper Sandler

Piper Sandler raised the firm’s price target on Illumina (ILMN) to $200 from $170 and keeps an Overweight rating on the shares. The firm believes 10x Genomics a...

Simply Wall St 1d

Illumina Board Expansion Puts Valuation Back In Focus

Advertisement Board expansion puts Illumina in focus Illumina (ILMN) has expanded its board from nine to ten directors and appointed Daniel M. Skovronsky, M.D...

Analyst ratings

52%

of 23 ratings

Buy

52.2%

Hold

26.1%

Sell

21.7%

More ILMN News

TipRanks 5d

Insider Shake-Up: General Dynamics, Autodesk, HPE, Macy’s, Illumina

Insiders have been trading these 5 stocks: ((GD)), ((ADSK)), ((HPE)), ((M)) and ((ILMN)). Here is a breakdown of their recent trades and their value. Unlock po...

People also own

Based on the portfolios of people who own ILMN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.